SEC Form 4 · accession 0001144204-15-061931
China Biologic Products, Inc. · CBPO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Gao
Officer — Chief Executive Officer · Director
Period of report
Oct 28, 2015
Accepted (ET)
Oct 30, 2015 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369868
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Oct 28, 2015 | S | 61,660 | $110.23 | D | 495,340 | D | |
| Common StockF1,F3 | Oct 29, 2015 | S | 9,458 | $110.08 | D | 485,882 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents 71,118 shares of common stock sold through a 10b5-1 trading plan previously disclosed on the Reporting Person's Form 4 filed with the Securities and Exchange Commission (the "Commission") on October 21, 2015.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $110.00 to $110.78, inclusive.*
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $110.00 to $110.96, inclusive.*
Remarks
* The Reporting Person undertakes to provide to any security holders of the Issuer or the staff of the Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in Footnotes 2 and 3.